Etrasimod tablets (Etrasimod)-Velsipity price, drug purchase channels and medication costs

Etrasimod (trade name Velsipity) is an oral small molecule immune-modulating drug mainly used to treat moderately to severely active ulcerative colitis. Its mechanism of action is to selectively regulate S1P receptor subtypes and inhibit the migration of lymphocytes to inflammatory sites, thereby reducing intestinal inflammatory response. FDAapproved itrimod tablets for marketing in the United States in October 2023, making it a new treatment option for ulcerative colitis.

In terms of price, because Itramod tablets have not yet been launched in China and are not included in medical insurance, patients cannot directly obtain them through formal channels in China. There are two types of foreign original medicines, the European version and the American version. Each box of the European version sells for about RMB 10,000 to RMB 30,000. The price may vary depending on the region and exchange rate fluctuations. The price of the American version of the drug is generally slightly higher than that of the European version, but the specific selling price needs to refer to the reimbursement situation of the American pharmacy or the medical insurance system.

In terms of drug purchase channels, if domestic patients need to use Itrimod tablets, they usually need to obtain medical treatment in overseas hospitals, international patient services or overseas drug purchase platforms. It should be noted that when purchasing drugs across borders, you need to ensure that the sources of drugs are formal and reliable, and at the same time comply with relevant customs and drug import regulations to avoid risks caused by counterfeit drugs or drugs from informal channels. In addition, because it is not available on the market in China, it cannot be covered by medical insurance reimbursement, and patients need to bear all drug costs out of their own pocket.

Overall, itrimod tablets have significant potential in the treatment of moderate to severe ulcerative colitis, but domestic availability is limited. Overseas original drugs are expensive and there are currently no generic drugs, resulting in higher drug costs. Clinically, if you consider using itridimod tablets, you need to fully evaluate the patient's financial affordability and access channels, and also pay attention to long-term medication safety and standardized monitoring to ensure the effectiveness and feasibility of the treatment plan.

Keyword tags: itramod, ulcerative colitis, price, overseas drug purchase, unlisted

References:https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-velsipity